A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection.

about

A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection.

Item

http://www.wikidata.org/entity/Q40298230

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A recombinant multi-epitope pr ...... onses against HIV-1 infection.

@en

type

Item

label

A recombinant multi-epitope pr ...... onses against HIV-1 infection.

@en

prefLabel

A recombinant multi-epitope pr ...... onses against HIV-1 infection.

@en

P1476

A recombinant multi-epitope pr ...... onses against HIV-1 infection.

@en

P2093

Jingjing Guo

http://www.w3.org/2001/XMLSchema#string

Junfeng Li

http://www.w3.org/2001/XMLSchema#string

Qiao Li

http://www.w3.org/2001/XMLSchema#string

Qing Zhu

http://www.w3.org/2001/XMLSchema#string

Weilai Sun

http://www.w3.org/2001/XMLSchema#string

Xiuzhe Ning

http://www.w3.org/2001/XMLSchema#string

Yan Guo

http://www.w3.org/2001/XMLSchema#string

Yi Yang

http://www.w3.org/2001/XMLSchema#string

Yusen Zhou

http://www.w3.org/2001/XMLSchema#string

Zhihua Kou

http://www.w3.org/2001/XMLSchema#string

P2860

Design and pre-clinical evaluation of a universal HIV-1 vaccine

Approaches to preventative and therapeutic HIV vaccines

HIV-Host Interactions: Implications for Vaccine Design

New concepts in HIV-1 vaccine development

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

Targeting early infection to prevent HIV-1 mucosal transmission.

Programming the magnitude and persistence of antibody responses with innate immunity.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1281488

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28281860

http://www.w3.org/2001/XMLSchema#string

P932

5489306

http://www.w3.org/2001/XMLSchema#string